ArticleBMC cancer2022

Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models.

Douglas D Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.